Identification of Immunodominant Proteins of the SubProteome as Pan-Specific Vaccine Targets against Leishmaniasis.

is a wide-spectrum disease caused by parasites from genus. A well-modulated immune response that is established after the long-lasting clinical cure of leishmaniasis can represent a standard requirement for a vaccine. Previous studies demonstrated that causes benign disease and its antigens induce well-modulated immune responses in vitro.